Obstructive Sleep Apnea Airway Evaluation
Developing a Novel Clinical Tool to Evaluate Obstructive Sleep Apnea (OSA) with Airway Ultrasound
1 other identifier
observational
200
1 country
1
Brief Summary
Current practice guidelines recommend obstructive sleep apnea (OSA) patients to stay in the post anesthetic care unit (PACU) until the risk of respiratory depression has subsided. Inevitably, a greater demand on hospital resource utilization in these patients will increase health care cost. Polysomnography (PSG) and screening questionnaires can identify OSA but they are limited by accessibility and false positive results, respectively. Inaccurate OSA identification misguides postoperative surveillance plan. In contrast with MRI and CT scans, ultrasound is more accessible and more likely a practical tool for OSA screening. However, before clinical application, airway ultrasound (US) exam must undergo vigorous testing to check its utility, accuracy, inter-observer reliability and its ability to identify OSA and its severity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2017
CompletedFirst Submitted
Initial submission to the registry
November 14, 2017
CompletedFirst Posted
Study publicly available on registry
December 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedDecember 11, 2024
December 1, 2024
4.9 years
November 14, 2017
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation of airway parameter measurements with Apnea-Hypopnea Index (AHI) values on Polysomnography (PSG)
The primary study outcome will be the discriminatory performance of each one of the airway parameters, against the OSA status (moderate/severe) as diagnosed by PSG.
2 years
Secondary Outcomes (1)
Feasibility of airway Ultrasound (US) examination;
2 years
Eligibility Criteria
Suspected / Recently diagnosed untreated Obstructive Sleep Apnea (amendment authorized 20/12/2017) / Non-compliant to OSA treatment
You may qualify if:
- age≥18
- ASA physical status I - IV;
- Suspected to have OSA for clinical reasons such as high risk on screening questionnaire i.e., a STOP-Bang score \>3, and referred to have a sleep study for OSA diagnosis by the clinical team at any point of care during the perioperative period (such as the clinic using the screening tool, during or after surgery in the ward experiencing recurrent upper airway obstructive events, need for CPAP in the postoperative period and / or suspected to have obstructive airway events). Or;
- Patients who were recently diagnosed to have OSA and underwent a laboratory sleep study within the last year.
- Patients who were recently diagnosed to have OSA but are non-compliant with treatment. Compliance defined as: median nightly CPAP or APAP use \> 70% of the nights, and for longer than 4 hours of nightly use during the last 3 months),43 or using oral appliance use (use \> 70% of nights, and for longer than 4 hours of nightly use in the last 3 months.
You may not qualify if:
- failure to understand and provide consent
- past history of oral, head and neck surgery (e.g., OSA corrective surgery)
- active head \& neck disease (e.g., cancer, infection and radiotherapy);
- inability to perform breathing tests per instruction
- Patients currently on treatment for OSA (as this may interfere with the upper airway dimensions and the US assessment may not be accurate)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto Western Hospital
Toronto, Ontario, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mandeep Singh
Department of Anesthesia, Toronto Western Hospital- UHN, University of Toronto
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2017
First Posted
December 5, 2017
Study Start
July 20, 2017
Primary Completion
June 30, 2022
Study Completion
September 30, 2022
Last Updated
December 11, 2024
Record last verified: 2024-12